Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid is an experimental small molecule belonging to the class of p-terphenyls. It is a brequinar-derived asymmetric terphenyl compound with the molecular formula C20H15NO3 and a molecular weight of approximately 317.34 g/mol[1][2][8]. The compound has been studied as an inhibitor of dihydroorotate dehydrogenase (quinone), mitochondrial (DHODH), with reported enzyme inhibition activity in vitro (Ki = 2.8 µM)[2][5]. There are no approved indications or clinical trials beyond preclinical/biochemical studies, and it is not marketed as a pharmaceutical product[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid.